Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Tata Business Cycle Fund · Regular ✕HDFC Pharma and Healthcare Fund · Regular ✕

Growth of ₹10,000

Basics

Tata Business Cycle FundHDFC Pharma and Healthcare Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseTataHDFC
NAV₹18.7331₹22.8170
NAV date20 Nov 202620 Nov 2026
History5.3 years3.1 years
Expense ratio2.2%2.1%
Stars★★★★★★★★★★
Growth Score38.0093.90

Returns

Tata Business Cycle FundHDFC Pharma and Healthcare Fund
1 month+6.60%+12.87%
3 months−2.33%+6.85%
6 months+1.38%+17.20%
YTD−1.34%+32.43%
1 year−1.90%+30.73%
3 years (CAGR)+8.94%+29.16%
5 years (CAGR)+11.85%—
10 years (CAGR)——
Since launch+12.66%+30.28%

Risk

Tata Business Cycle FundHDFC Pharma and Healthcare Fund
Volatility16.3%15.8%
Downside volatility11.3%8.6%
Sharpe0.151.44
Sortino0.222.64
Calmar0.441.94
Return / risk0.551.85
Deepest fall−20.50%−15.07%
Days to recover—133
Below its high−9.41%+0.00%

Against benchmark

Tata Business Cycle FundHDFC Pharma and Healthcare Fund
Alpha−2.51%+6.36%
Beta0.980.97
R²93.8%85.0%
Up capture94.3%106.7%
Down capture107.3%74.4%
Tracking error4.1%6.1%
Information ratio−0.640.97
Treynor0.020.22

Consistency

Tata Business Cycle FundHDFC Pharma and Healthcare Fund
Best 1-year+55.11%+64.96%
Middle 1-year+8.65%+21.84%
Worst 1-year−11.49%+0.52%
1-year periods with a loss19.2%0.0%
Middle 3-year+17.74%+28.68%
Positive months63.9%69.4%
Best day+4.03%+3.19%
Worst day−7.35%−3.62%
Worst 5% day−1.62%−1.50%
Positive days56.1%58.1%
NAVs a year247247

SIP of ₹10,000 a month

Tata Business Cycle FundHDFC Pharma and Healthcare Fund
5-year XIRR+9.77%—
5-year value₹7,71,179—
3-year XIRR+2.35%+26.26%
1-year XIRR+1.67%+39.84%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth